IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Effect of Prenatal Infusion of Magnesium Sulphate on Neurological Complication in Preterm Infant

Author: HALSHO MUHAMMED, SRWA JAMAL MURAD
Abstract: Preterm infants are infants who are born more than 24 weeks of gestation but less than37 weeks. With the advances of medicine the survival rate of this infants have increased. But increase in neurological abnormalities is a matter of concern. Some studies shows that intravenous administration of magnesium sulphate has neuroprotective effect. To asses nueroprotictive effect of maternal intravenous administration of magnesium sulphate on neurological outcome of neonates in preterm deliveries In a randomized controlled trail 60 mothers divided in to two groups of 28 and 32 cases were included in this study. The first group received intravenous magnesium sulphate, the second received just normal saline. Follow up of the babies was done for 28 days postnatal. Ultrasound of brain performed at seven days and at 28 days postnatal a pediatrician viewed the neonate to assess the presence of any neurological abnormality.The Apgar score for the group who received the drug was more both at one and five minutes. Mortality rate in this group was (3.5%) at the time the group with placebo had mortality rate of (22%) (Pvalue was 0.02) , duration of the intensive care unit stay was less in the first group Intraventricular hemorrhage was present in 1 case of the second group. Intravenous magnesium administration is cost effective as saved 40000 $ during the period of follow up. Magnesium sulphate has neuroprotective effect on neonate. There was decrease in mortality in the group who received it. Duration of the intensive care unit stay was less, too. Larger sample size may be necessary to have a better estimate of outcome.
Keyword: Magnesium sulphate, neonatal care unit (NCU), Cerebral Palsy (CP), APGAR Score, Cost-effectiveness
DOI: https://doi.org/10.31838/ijpr/2019.11.03.005
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477